MyFinsight
Home
Blog
About
Back
Balance Sheet
Nuvectis Pharma, Inc. (NVCT)
Nuvectis Pharma, Inc. (NVCT)
source: myfinsight.com
Cash and cash
equivalents
$22,160K
(-17.29%↓ Y/Y)
Other current assets
$216K
(0.93%↑ Y/Y)
Total current assets
$22,376K
(-17.15%↓ Y/Y)
Total assets
$22,376K
(-17.15%↓ Y/Y)
Total liabilities and
shareholders' equity
$22,376K
(-17.15%↓ Y/Y)
Total liabilities
$13,294K
(31.17%↑ Y/Y)
Total shareholders'
equity
$9,082K
(-46.17%↓ Y/Y)
Accumulated deficit
-$112,757K
(-32.79%↓ Y/Y)
Total current
liabilities
$13,294K
(31.17%↑ Y/Y)
Additional paid in capital
$121,839K
(19.70%↑ Y/Y)
Employee compensation
and benefits
$6,630K
(30.49%↑ Y/Y)
Accounts payable
$5,184K
(4.16%↑ Y/Y)
Deferred fundraising
receipts
$1,388K
Accrued liabilities
$92K
(4500.00%↑ Y/Y)
Back